These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20926575)

  • 21. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.
    Lu XB; Heimer J; Rekosh D; Hammarskjöld ML
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7598-602. PubMed ID: 2217190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages.
    Dowling D; Nasr-Esfahani S; Tan CH; O'Brien K; Howard JL; Jans DA; Purcell DF; Stoltzfus CM; Sonza S
    Retrovirology; 2008 Feb; 5():18. PubMed ID: 18241354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    O'Reilly MM; McNally MT; Beemon KL
    Virology; 1995 Nov; 213(2):373-85. PubMed ID: 7491762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
    Wong RW; Balachandran A; Cheung PK; Cheng R; Pan Q; Stoilov P; Harrigan PR; Blencowe BJ; Branch DR; Cochrane A
    PLoS Pathog; 2020 Feb; 16(2):e1008307. PubMed ID: 32069328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.
    Purcell DF; Martin MA
    J Virol; 1993 Nov; 67(11):6365-78. PubMed ID: 8411338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.
    Barajas BC; Tanaka M; Robinson BA; Phuong DJ; Chutiraka K; Reed JC; Lingappa JR
    PLoS Pathog; 2018 Apr; 14(4):e1006977. PubMed ID: 29664940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b.
    Brillen AL; Walotka L; Hillebrand F; Müller L; Widera M; Theiss S; Schaal H
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing the CpG dinucleotide abundance in the HIV-1 genomic RNA inhibits viral replication.
    Antzin-Anduetza I; Mahiet C; Granger LA; Odendall C; Swanson CM
    Retrovirology; 2017 Nov; 14(1):49. PubMed ID: 29121951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gag-processing defect of human immunodeficiency virus type 1 integrase E246 and G247 mutants is caused by activation of an overlapping 5' splice site.
    Mandal D; Feng Z; Stoltzfus CM
    J Virol; 2008 Feb; 82(3):1600-4. PubMed ID: 18032510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element.
    Garzino-Demo A; Gallo RC; Arya SK
    Hum Gene Ther; 1995 Feb; 6(2):177-84. PubMed ID: 7734518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of retroviral Gag-host cell interactions: focus on the nuclear interactome.
    Lambert GS; Rice BL; Maldonado RJK; Chang J; Parent LJ
    Retrovirology; 2024 Jun; 21(1):13. PubMed ID: 38898526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Rev-CBP80-eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA.
    Toro-Ascuy D; Rojas-Araya B; García-de-Gracia F; Rojas-Fuentes C; Pereira-Montecinos C; Gaete-Argel A; Valiente-Echeverría F; Ohlmann T; Soto-Rifo R
    Nucleic Acids Res; 2018 Nov; 46(21):11539-11552. PubMed ID: 30239828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Gag Forms Ribonucleoprotein Complexes with Unspliced Viral RNA at Transcription Sites.
    Tuffy KM; Maldonado RJK; Chang J; Rosenfeld P; Cochrane A; Parent LJ
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer.
    Asang C; Hauber I; Schaal H
    Nucleic Acids Res; 2008 Mar; 36(5):1450-63. PubMed ID: 18203748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication.
    Takata MA; Soll SJ; Emery A; Blanco-Melo D; Swanstrom R; Bieniasz PD
    PLoS Pathog; 2018 Jan; 14(1):e1006824. PubMed ID: 29377940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshifting.
    Roesmann F; Sertznig H; Klaassen K; Wilhelm A; Heininger D; Heß S; Elsner C; Marschalek R; Santiago ML; Esser S; Sutter K; Dittmer U; Widera M
    J Virol; 2024 Jul; 98(7):e0053424. PubMed ID: 38899932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.